Early Detection and Differential Diagnosis of
Brain Abnormalities at the Point of Care

FDA

90% of Strokes & 35% of Dementias are Preventable

Direct ElectroPhysiology Imaging

The First Non-Invasive Probe
for Direct Brain Network Visualization

The Delphi·MD device provides first-in-class direct brain network visualization for a quantitative neuronal function analysis, empowering clinicians with a definitive neurodiagnosis and clinical decision support.
The Technology >
Delphi

Watch Video >

X

Objective & direct
Objective & Direct
Fully automated & real-time
Fully Automated
& Real-Time
Applicable in any clinical setting
Applicable in Any
Clinical Setting
Extremely accurate
Extremely Accurate
Highly sensitive
Highly Sensitive
Safe & Accessible
Safe & Accessible

Certifications:

FDA Breakthrough Designation
FDA Breakthrough
Designation

* Delphi-MD is not approved for commercial use in the United States;

CE Marked
Delphi software CE Marked

* Delphi-MD is not approved for commercial use in the United States;

ISO 13485 Certified
ISO 13485
Certified

* Delphi-MD is not approved for commercial use in the United States;

Partnerships

Delphi·MD in the Clinic

Patient lays comfortably
Patient Lays
Comfortably
Delphi·MD probes brain network function
Delphi·MD Probes
Brain Network
Function
Delphi·MD output Report is produced
Delphi·MD
Output Report
is Produced
Neurologist performs Early detection and diagnosis
Neurologist Performs
Early Detection
and Diagnosis
HP Clinic

Confidence Through Evidence

Delphi·MD in Stroke and TBI

Evaluation of White Matter Integrity Utilizing the Delphi·MD System. Front Neurosci. 2020 Dec 21;14:589107.

Read More >
Delphi·MD in stroke and TBI

Delphi·MD for Detection of Healthy VS Unhealthy Brain Ageing

Introducing a Novel Approach for Evaluation & Monitoring of Brain Health Across Life Span Using Direct Non-invasive Brain Network Electrophysiology. Front Aging Neurosci. 2019 Sep 9;11:248.

Read More >
Delphi·MD for detection of Healthy vs unhealthy brain aging

Delphi·MD in Parkinson’s Disease

A multimodal approach using TMS and EEG reveals neurophysiological changes in Parkinson’s disease, Parkinsonism & Related Disorders, Parkinsonism related dis. 2021 Jun 18 ; 89:28;

Read More >
Delphi·MD in Parkinson’s disease

Delphi·MD as Early Dementia \ Alzheimer’s Biomarker

Brain Network Integrity Changes in Subjective Cognitive Decline,  a Possible Physiological Biomarker of Dementia Journal: Fronti Neurology. 2021 July

Read More >
Delphi·MD as Early dementia \Alzheimer’s Biomarker

News & Events

See Delphi-MD in action

WATCH VIDEO

Nov 14, 2022

Delphi-MD Breakthrough diagnostic technology promises to reduce healthcare burden by detecting brain abnormalities prior to symptoms, at the point of care

PRESS RELEASE PRESS RELEASE
HP News background

Contact Us

    Application

    Neuro
    Diagnostics

    Contact
    Skip to content